FOI release

Yellow Card Scheme regarding side-effects of the Adjuvanted Trivalent Influenza

Case reference FOI2026/00644

Received 12 June 2026

Published 10 August 2026

Request

Could you advise me where I can find details of reports made to the Yellow Card Scheme regarding side-effects of the Adjuvanted Trivalent Influenza Vaccine, commonly known as TIV, and brand name of Fluad, for 2020, please?

Response

See attached

Documents

• DAP guidance 2020.pdf (119.5 KB)
• FOI2026_00644 (redacted).pdf (841.9 KB)
• Product Analysis Print (PAP) - Fluad (2020).pdf (160.2 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.